A phase I trial for the use of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) in the treatment of BCG-refractory nonmuscle invasive urothelial carcinoma of the bladder.

被引:9
|
作者
DeCastro, Guarionex Joel
Sui, Wilson
Pak, Jamie S.
Abate-Shen, Corinne T.
Lee, Shing Mirn
Anderson, Christopher B.
机构
关键词
D O I
10.1200/JCO.2017.35.6_suppl.313
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
313
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    DeCastro, Guarionex
    Sui, Wilson
    Pak, Jamie
    Abate-Shen, Cory
    Lee, Shing
    Anderson, Christopher
    Holder, Dara
    McKiernan, James
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E175 - E176
  • [2] Phase 2 trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladder.
    DeCastro, Guarionex Joel
    Anderson, Christopher B.
    Abate-Shen, Cory
    Gray, Jillian
    Ingram, Justin
    Stein, Mark N.
    McKiernan, James M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] A PHASE 1 TRIAL OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) FOR THE TREATMENT OF NON-MUSCLE INVASIVE BCG UNRESPONSIVE UROTHELIAL CARCINOMA OF THE BLADDER
    DeCastro, G. Joel
    Anderson, Christopher
    Kates, Max
    Buckley-Matura, Bridget
    Sui, Wilson
    Lee, Shing M.
    Holder, Dara
    Virk, Renu
    Drake, Charles
    Abate-Shen, Cory
    McKiernan, James
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E623 - E623
  • [4] Phase I trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Sheinfeld, J
    Mazumdar, M
    Tong, W
    Rabbani, F
    Donat, SM
    Herr, HW
    Sogani, P
    Depalma, D
    Bajorin, D
    [J]. JOURNAL OF UROLOGY, 2002, 167 (04): : 186 - 186
  • [5] A Phase I Trial of Intravesical Cabazitaxel, Gemcitabine and Cisplatin for the Treatment of Nonmuscle Invasive bacillus Calmette-Guerin Unresponsive or Recurrent/Relapsing Urothelial Carcinoma of the Bladder
    DeCastro, Guarionex J.
    Sui, Wilson
    Pak, Jamie S.
    Lee, Shing M.
    Holder, Dara
    Kates, Max M.
    Virk, Renu K.
    Drake, Charles G.
    Anderson, Christopher B.
    James, Bridget
    Abate-Shen, Cory T.
    McKiernan, James M.
    [J]. JOURNAL OF UROLOGY, 2020, 204 (02): : 247 - 253
  • [6] Phase II trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Ben-Porat, L
    Donat, SM
    Herr, HW
    Bochner, BH
    Bajorin, DF
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 270 - 271
  • [7] Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial
    Perdona, Sisto
    Di Lorenzo, Giuseppe
    Cantiello, Francesco
    Damiano, Rocco
    De Sio, Marco
    Masala, Daniele
    Bruni, Gianni
    Gallo, Luigi
    Federico, Piera
    Quattrone, Carmelo
    Pizzuti, Mariano
    Autorino, Riccardo
    [J]. ANTI-CANCER DRUGS, 2010, 21 (01) : 101 - 106
  • [8] Endovesical treatment with gemcitabine in patients with BCG-refractory superficial bladder carcinoma
    Gunelli, R.
    Frassineti, G. L.
    Giovannini, N.
    Zoli, W.
    Fiori, M.
    Amadori, D.
    Fabbri, P.
    Bercovich, E.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI78 - XI78
  • [9] ENDOVESICAL TREATMENT WITH GEMCITABINE IN PATIENTS WITH BCG-REFRACTORY SUPERFICIAL BLADDER CARCINOMA
    Gunelli, Roberta
    Frassineti, Giovanni Luca
    Giovannini, Noemi
    Zoli, Wainer
    Fiori, Massimo
    Saltutti, Carlo
    Amadori, Dino
    Bercovich, Eduard
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 95 - 96
  • [10] Phase II trial of intravesical gemcitabine in BCG refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Mazumdar, M
    Russo, P
    Sheinfeld, J
    Donat, SM
    Bochner, BH
    Herr, HW
    Sogani, P
    Ginty, J
    Bajorin, DF
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 72 - 72